达比加群乙酸乙酯 T15046

Product Introduction
Bioactivity


英文名: Dabigatran ethyl ester

描述: Dabigatran ethyl ester (Dabigatran (ethyl ester)) 是新型的口服抗凝化合物和凝血酶抑制剂。

体外活性: Dabigatran etexilate was rapidly converted to Dabigatran, with peak plasma dabigatran concentrations being attained after approximately 1.5 h. there is a growing amount of clinical evidence which shows its safety and efficacy. Dabigatran may suppose a revolution in oral anticoagulation. The bioavailability of Dabigatran after p.o. administration of Dabigatran etexilate was 7.2%[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 1 mg/mL (2.00 mM)
H2O : 1 mg/mL (2.00 mM)


关键字: Dabigatran | ethyl ester

相关产品: Odiparcil | Thrombin receptor peptide ligand | Ximelagatran | Melagatran | Avatrombopag | AEBSF hydrochloride | Dabigatran ethyl ester hydrochloride | Z-Gly-Pro-Arg-4MβNA | p-Hydroxycinnamic acid | Protamine sulfate

达比加群乙酸乙酯 T15046信息由TargetMol中国为您提供，如您想了解更多关于达比加群乙酸乙酯 T15046报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途